950
Views
64
CrossRef citations to date
0
Altmetric
Review Articles

Cadmium or cadmium compounds and chronic kidney disease in workers and the general population: a systematic review

, , , &
Pages 191-240 | Received 26 Mar 2015, Accepted 22 Jul 2015, Published online: 29 Oct 2015

References

  • Abbasi M, Chertow GM, Hall YN. End-stage renal disease. In: BMJ Evidence Center, editor. Clinical evidence handbook. London: BMJ Publishing Group; 2014. pp 309–311.
  • ACGIH. 2013 TLVs and BEIs Threshold limit values for chemical substances and physical agents & biological exposure indices. Cincinnati (OH): American Conference of Governmental Industrial Hygienists; 2013. pp 1–242.
  • Adams RG. Clinical and biochemical observations in men with cadmium nephropathy. A twenty-years study. Arh Hig Rada Toksikol 1979;30:219–231.
  • Adams RG. An analysis of mortality from nephritis and nephrosis among nickel–cadmium battery workers. In: Wilson D, Volpe RA, editors. Cadmium 83. Edited proceedings. Fourth international cadmium conference. Munich. London, New York: Cadmium Association; Cadmium Council Inc.; International Lead Zinc Research Association; 1983. pp 155–156.
  • Adams RG. Manufacturing process, resultant risk profiles and their control in the production of nickel–cadmium (alkaline) batteries. Occup Med 1992;42:101–106.
  • Adams RG, Harrison JF, Scott P. The development of cadmium-induced proteinuria, impaired renal function, and osteomalacia in alkaline battery workers. Quart J Med 1969;38:425–443.
  • Adams SV, Newcomb PA. Cadmium blood and urine concentrations as measures of exposure: NHANES 1999–2010. J Expo Sci Environ Epidemiol 2014;24:163–170.
  • Adamsson E. Long-term sampling of airborne cadmium dust in an alkaline battery factory. Scand J Work Environ Health 1979;5:178–187.
  • Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for cadmium. Atlanta (GA): Agency for Toxic Substances and Disease Registry (ATSDR); U.S. Department of Health and Human Services; 2012. pp 1–430.
  • Ahlmark A, Axelsson B, Friberg L, Piscator M. Further investigations into kidney function and proteinuria in chronic cadmium poisoning. Proceedings of the 13th International Congress on Occupation and Health, New York City 1961;201–203.
  • Akerstrom M, Barregard L, Lundh T, Sallsten G. The relationship between cadmium in kidney and cadmium in urine and blood in an environmentally exposed population. Toxicol Appl Pharmacol 2013b;268:286–293.
  • Akerstrom M, Barregard L, Lundh T, Sallsten G. Variability of urinary cadmium excretion in spot urine samples, first morning voids, and 24 h urine in a healthy non-smoking population: implications for study design. J Expo Sci Environ Epidemiol 2014;24:171–179.
  • Akerstrom M, Lundh T, Barregard L, Sallsten G. Effect of molybdenum oxide interference on urinary cadmium analyses. Int Arch Occup Environ Health 2013c;86:615–617.
  • Akerstrom M, Sallsten G, Lundh T, Barregard L. Associations between urinary excretion of cadmium and proteins in a nonsmoking population: renal toxicity or normal physiology? Environ Health Perspect 2013a;121:187–191.
  • Akesson A, Barregard L, Bergdahl IA, Nordberg GF, Nordberg M, Skerfving S. Non-renal effects and the risk assessment of environmental cadmium exposure. Environ Health Perspect 2014;122:431–438.
  • Al-Aly Z. Prediction of renal end points in chronic kidney disease. Kidney Int 2013;83:189–191.
  • Andersson K, Elinder CG, Hogstedt C, Kjellström T, Spang G. Mortality among cadmium and nickel-exposed workers in a Swedish battery factory. Toxicol Environ Chem 1984;9:53–62.
  • Ando Y, Shibata E, Tsuchiyama F, Sakai S. Elevated urinary cadmium concentrations in a patient with acute cadmium pneumonitis. Scand J Work Environ Health 1996;22:150–153.
  • Andreev E, Koopman M, Arisz L. A rise in plasma creatinine that is not a sign or renal failure: which drugs can be responsible? J Intern Med 1999;246:247–252.
  • Anglov T, Holst E, Christensen JM. Danish external quality assessment scheme: an interlaboratory comparison study on lead, cadmium and chromium in lyophilized human blood concentrate. Int Arch Occup Environ Health 1993;64:431–438.
  • Anonymous. Technical report of EFSA prepared by assessment methodology unit on meta-analysis of dose–effect relationship of cadmium for benchmark dose evaluation. EFSA Sci Rep 2009a;254:1–62.
  • Anonymous. Scientific opinion of the panel on contaminants in the food chain on a request from the European Commission on cadmium in food. 8.4.2.1. Effects on kidney. EFSA J 2009b;980:69–82.
  • Arisawa K, Nakano A, Saito H, Liu XJ, Yokoo M, Soda M, Koba T, et al. Mortality and cancer incidence among a population previously exposed to environmental cadmium. Int Arch Occup Environ Health 2001;74:255–262.
  • Arisawa K, Uemura H, Hiyoshi M, Dakeshita S, Kitayama A, Saito H, Soda M. Cause-specific mortality and cancer incidence rates in relation to urinary beta 2-microglobulin: 23-year follow-up study in a cadmium-polluted area. Toxicol Lett 2007;173:168–174.
  • Armstrong R, Chettle DR, Scott MC, Blindt M, Mason HJ. Longitudinal studies of exposure to cadmium. Br J Ind Med 1992;49:556–559.
  • Armstrong BG, Kazantzis G. A mortality study of cadmium workers in England. A report to the Industrial Lead Zinc Research Organization, April 1982. London: TUC Centenary Institute of Occupational Health; London School of Hygiene and Tropical Medicine; 1982. p 1.
  • Armstrong BG, Kazantzis G. The mortality of cadmium workers. Lancet 1983;1:1425–1427.
  • Armstrong BG, Kazantzis G. Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: a case control study. Br J Ind Med 1985;42:540–545.
  • Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis 2012;59:653–662.
  • Austin PC, Mamdani MM, Juurlink DN, Hux JE. Testing multiple statistical hypotheses resulted in spurious associations: a study of astrological signs and health. J Clin Epidemiol 2006;59:964–969.
  • Aylward LL, Hays SM, Smolders R, Koch HM, Cocker J, Jones K, Warren N, et al. Sources of variability in biomarker concentrations. J Toxicol Environ Health Pt B 2014;17:45–61.
  • Baader EW. Die chronische Kadmiumvergiftung. Dtsch Med Wochenschr 1951;76:484–487.
  • Baader EW. Chronic cadmium poisoning. Ind Med Surg 1952;21:427–430.
  • Baines RJ, Brunskill NJ. The molecular interactions between filtered proteins and proximal tubular cells in proteinuria. Nephron Exp Nephrol 2008;110:e67–e71.
  • Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005;113:192–200.
  • Barton EN, Sargeant LA, Samuels D, Smith R, James J, Wilson R, Smith F, et al. A survey of chronic renal failure in Jamaica. West Indian Med J 2004;53:81–84.
  • Bash LD, Coresh J, Kottgen A, Parekh RS, Fulop T, Wang Y, Astor BC. Defining incident chronic kidney disease in the research setting. The ARIC study. Am J Epidemiol 2009;170:414–424.
  • Becker K, Schulz C, Kaus S, Seiwert M, Seifert B. German Environmental Survey 1998 (GerES III): environmental pollutants in the urine of the German population. Int J Hyg Environ Health 2003;206:15–24.
  • Bernard A. Biomarkers in surveillance of workers exposed to cadmium. Int J Occup Environ Health 1996;3:533–536.
  • Bernard A. Renal dysfunction induced by cadmium: biomarkers of critical effects. BioMetals 2004;17:519–523.
  • Bernard A. Biomarkers of metal toxicity in population studies: research potential and interpretation issues. J Toxicol Environ Health Pt A 2008;71:1259–1265.
  • Bernard A. Confusion about cadmium risks: the unrecognized limitations of an extrapolated paradigm. Environ Health Perspect 2015. [Epub ahead of print]. doi: 10.1289/ehp.1509691.
  • Bernard A, Stolte H, De Broe ME, Mueller PW, Mason H, Lash LH, Fowler BA. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. IV. Current information on interpreting the health implications of tests. Ren Fail 1997;19:553–566.
  • Blainey JD, Adams RG, Brewer DB, Harvey TC. Cadmium-induced osteomalacia. Br J Ind Med 1980;37:278–284.
  • Boffetta P, McLaughlin JK, Lavecchia C, Tarone RE, Lipworth L, Blot WJ. False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst 2008;100:988–995.
  • Boisson RC, Eynard JC, Crozier M, Grafmeyer DC. French experience of quality assessment of quantitative urinary analysis. Clin Chim Acta 2000;297:285–295.
  • Bonnell JA. Emphysema and proteinuria in men casting copper–cadmium alloys. Br J Ind Med 1955;12:181–195.
  • Bonnell JA, Kazantzis G, King E. A follow-up study of men exposed to cadmium oxide fume. Br J Ind Med 1959;16:135–147.
  • Bratveit M, Mageroy N, Gundersen H, Vahter M, Moen BE. Biomarker of chronic cadmium exposure in a population residing in the vicinity of a zinc producing plant. Sci Total Environ 2011;409:4222–4228.
  • Brown SS. Quantitative analyses of cadmium: quality assured? IARC Sci Publ 1992;118:73–81.
  • Buchet JP, Lauwerys R, Roels H, Bernard A, Bruaux P, Claeys F, Ducoffre G, et al. Renal effects of cadmium body burden of the general population (erratum appeared in Lancet (1991) 337: 1554). Lancet 1990;336:699–702.
  • Buchet JP, Staessen J, Roels H, Lauwerys R, Fagard R. Geographical and temporal differences in the urinary excretion of inorganic arsenic: A Belgian population study. Occup Environ Med 1996;53:320–327.
  • Chambers RE, Bullock DG, Whicher JT. External quality assessment of total urinary protein estimation in the United Kingdom. Ann Clin Biochem 1991;28:467–473.
  • Chang LW. Pathological effects of cadmium poisoning. In: Nriagu JO, editor. Cadmium in the environment. Part 2. Health effects. New York, Chichester, Brisbane: John Wiley & Sons; 1981. pp 783–839.
  • Chaumont A, Voisin C, Deumer G, Haufroid V, Annesi-Maesano I, Roels H, Thijs L, et al. Associations of urinary cadmium with age and urinary proteins: further evidence of physiological variations unrelated to metal accumulation and toxicity. Environ Health Perspect 2013;121:1047–1053.
  • Chen X, Zhu G, Jin T, Lei L, Liang Y. Bone mineral density is related with previous renal dysfunction caused by cadmium exposure. Environ Toxicol Pharmacol 2011;32:46–53.
  • Chiesura P, Trevisan A, Gori GP, Buzzo A, Calzavara V. Sul rischio di intossicazione da cadmio nella saldobrasatura. Med Lav 1984;75:300–305.
  • Christensen EI, Verroust PJ, Nielsen R. Receptor-mediated endocytosis in renal proximal tubule. Pflugers Arch 2009;458:1039–1048.
  • Claeys F, Ducoffre G, Sartor F, Roels H. Analytical quality control of cadmium and lead in blood and cadmium in urine: results of its implementation during a five-year epidemiologic study. IARC Sci Publ 1992;118:83–92.
  • Clase C. Renal failure (chronic). In: BMJ Evidence Center, editor. Clinical evidence handbook. London: BMJ Publishing Group; 2014. pp 315–318.
  • Colacino JA, Arthur AE, Ferguson KK, Rozek LS. Dietary antioxidant and anti-inflammatory intake modifies the effect of cadmium exposure on markers of systemic inflammation and oxidative stress. Environ Res 2014;131:6–12.
  • Coresh J, Astor BC, Mcquillan G, Kusek J, Green T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002;39:920–929.
  • Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014;311:2518–2531.
  • Cornelis R, Heinzow B, Herber RFM, Christensen JM, Poulsen OM, Sabbioni E, Templeton DM, et al. Sample collection guidelines for trace elements in blood and urine. J Trace Elem Med Biol 1996;10:103–127.
  • Davey Smith G, Ebrahim S. Data dredging, bias, or confounding. Br Med J 2002;325:1437–1438.
  • Davies JM. Mortality among workers at two copper works where cadmium was in use (abstract). Br J Prev Soc Med 1972;26:59.
  • De Broe ME, D'Haese PC, Elseviers MM. Chronic tubulointerstitial nephritis. In: Warrell DA, Cox TM, Firth JD, Benz EJ, editors. Oxford textbook of medicine. Oxford: Oxford University Press; 2003. pp 3.361–3.373.
  • De Marchi S, Cecchin E, Basile A, Bertotti A, Nardini R, Bartoli E. Renal tubular dysfunction in chronic alcohol abuse – effects of abstinence. N Engl J Med 1993;329:1927–1934.
  • De Silva PE, Donnan MB. Chronic cadmium poisoning in a pigment manufacturing plant. Br J Ind Med 1981;38:76–86.
  • Devulder B, Martin JC, Plouvier B, Le Bouffant L, Tacquet A, Furon D. Les aspects ultrastructuraux de la nephropathie cadmique humaine et experimentale. Arch Mal Prof 1978;39:35–43.
  • Dewell P. Concentrations of cadmium in air and urine in an alkaline battery works. Ann Occup Hyg 1994;38:209–218.
  • Dickson LE, Wagner MC, Sandoval RM, Molitoris BA. The proximal tubule and albuminuria: really! J Am Soc Nephrol 2014;25:443–453.
  • Dieperink HH. Identification of groups at risk for renal diseases (including nephrotoxicity). Toxicol Lett 1989;46:257–268.
  • Donadio C. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein. Am J Physiol Renal Physiol 2010;299:F1407–F1423.
  • Dyer O. CDC will explore kidney failure epidemic among agricultural workers. Br Med J 2014;348:g3385.
  • Elinder CG. Epidemiology and toxicity of cadmium. In: Curhan GC, Sheridan AM, editors. UpToDate. Amsterdam: Wolters Kluwer Health; 2013. pp 1–14.
  • Elinder CG, Edling C, Lindberg E, Kagedal B, Vesterberg O. Assessment of renal function in workers previously exposed to cadmium. Br J Ind Med 1985a;42:754–760.
  • Elinder CG, Edling C, Lindberg E, Kagedal B, Vesterberg O. β2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose–response analyses. Am J Ind Med 1985b;8:553–564.
  • Elinder CG, Kjellström T, Hogstedt C, Andersson K, Spang G. Cancer mortality of cadmium workers. Br J Ind Med 1985c;42:651–655.
  • Elinder CG, Järup L. Cadmium exposure and health risks: recent findings. Ambio 1996;25:370–373.
  • Ellam TJ. Albumin: creatinine ratio – a flawed measure? The merits of estimated albuminuria reporting. Nephron Clin Pract 2011;118:C324–C330.
  • Elliott P, Arnold R, Cockings S, Eaton N, Järup L, Jones J, Quinn M, et al. Risk of mortality, cancer incidence, and stroke in a population potentially exposed to cadmium. Occup Environ Med 2000;57:94–97.
  • Eriksen BO, Ingebretsen OC. In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int 2007;72:1242–1248.
  • European Food Safety Authority. Comparison of the approaches taken by EFSA and JECFA to establish a HBGV for cadmium. EFSA J 2011;9:2006.
  • Fangstrom B, Hamadani J, Nermell B, Grander M, Palm B, Vahter M. Impaired arsenic metabolism in children during weaning. Toxicol Appl Pharmacol 2009;239:208–214.
  • Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int 2011;80:806–821.
  • Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem 2012;58:680–689.
  • Fernandez J, Sanz-Gallen P, Nogue S. Follow-up of two patients with mesangial IgA glomerulonephritis exposed to cadmium and organic solvents. An Sist Sanit Navar 2010;33:309–313.
  • Ferraro PM, Costanzi S, Naticchia A, Sturniolo A, Gambaro G. Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999–2006. BMC Public Health 2010;10:304.
  • Forni Ogna V, Ogna A, Vuistiner P, Pruijm M, Ponte B, Ackermann D, Gabutti L, et al. New anthropometry-based age- and sex-specific reference values for urinary 24-hour creatinine excretion based on the adult Swiss population. BMC Med 2015;13:40.
  • Foster MC, Inker LA, Levey AS, Selvin E, Eckfeldt J, Juraschek SP, Coresh J. CKD Biomarkers Consortium. Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis 2013;62:42–51.
  • Franzblau F. Cadmium. In: Rosenstock L, Cullen MR, Brodkin CA, Redlich CA, editors. Textbook of clinical occupational and environmental medicine. Philadelphia, Edinburgh, London, New York: Elsevier Saunders; 2005. pp 955–957.
  • Frery N, Saoudi A, Garnier R, Zeghnoun A, Falq G. Exposition de la population francaise aux substances chimiques de l'environnement. Saint-Maurice: Institut de Veille Sanitaire; 2011. pp 1–151.
  • Friberg L. Proteinuria and kidney injury among workmen exposed to cadmium and nickel dust. Preliminary report. J Ind Hyg Toxicol 1948;30:32–36.
  • Friberg L. Health hazards in the manufacture of alkaline accumulators with special reference to chronic cadmium poisoning. Acta Med Scand 1950a;138:1–124.
  • Friberg L. Injuries following continued administration of cadmium. Preliminary report of a clinical and experimental study. Arch Ind Hyg Occup Med 1950b;1:458–466.
  • Friberg L. Chronic cadmium poisoning. AMA Arch Ind Health 1959;20:401–407.
  • Friberg L. Cadmium and the kidney. Environ Health Perspect 1984;54:1–11.
  • Friberg L, Nyström A. Synpunkter pa den kroniska kadmiumforgiftningens prognos. Sven Lakartidn 1952;49:2629–2638.
  • Friberg L, Piscator M, Nordberg G. Renal effects and dose–response relationships. In: Friberg L, Piscator M, Nordberg G, editors. Cadmium in the environment. Cleveland (OH): CRC Press, Inc.; 1971. pp 79–90.
  • Friberg L, Piscator M, Nordberg GF, Kjellström T. Cadmium in the environment. Cleveland (OH): CRC Press, Inc.; 1974. pp 1–227.
  • Friberg L, Vahter M. Assessment of exposure to lead and cadmium through biological monitoring: results of a UNEP/WHO global study. Environ Res 1983;30:95–128.
  • Fukushima M, Nogawa K, Kobayashi E. Reexamination of the urine from the inhabitants in the Itai-Itai disease endemic village after five years since the first examination. Jpn J Public Health 1972;19:406.
  • Gamo M, Ono K, Nakanishi J. Meta-analysis for deriving age- and gender-specific dose–response relationships between urinary cadmium concentration and beta(2)-microglobulinuria under environmental exposure. Environ Res 2006;101:104–112.
  • Gena P, Calamita G, Guggino WB. Cadmium impairs albumin reabsorption by down-regulating megalin and ClC5 channels in renal proximal tubule cells. Environ Health Perspect 2010;118:1551–1556.
  • Gil HW, Kang EJ, Lee KH, Yang JO, Lee EY, Hong SY. Effect of glutathione on the cadmium chelation of EDTA in a patient with cadmium intoxication. Hum Exp Toxicol 2011;30:79–83.
  • Ginsberg GL. Cadmium risk assessment in relation to background risk of chronic kidney disease. J Toxicol Environ Health Pt A 2012;75:374–390.
  • Glenn GC. The CAP urine chemistry survey program for 1977. Am J Clin Pathol 1978;70:513–515.
  • Glenn GC. The results of analyte enhancement and use of supplied urine protein standard on the CAP urine chemistry survey program. Am J Clin Pathol 1980;74:531–534.
  • Goen T, Schaller KH, Drexler H. External quality assessment of human biomonitoring in the range of environmental exposure levels. Int J Hyg Environ Health 2012;215:229–232.
  • Goldberg M, Silbergeld E. On multiple comparisons and on the design and interpretation of epidemiological studies of many associations. Environ Res 2011;111:1007–1009.
  • Gompertz D, Chettle DR, Fletcher JG, Mason H, Perkins J, Scott MC, Smith NJ, et al. Renal dysfuntion in cadmium smelters: relation to in-vivo liver and kidney cadmium concentrations. Lancet 1983;1:1185–1187.
  • Gonick HC. Nephrotoxicity of cadmium & lead. Indian J Med Res 2008;128:335–352.
  • Gotzsche PC, Hrobjartsson A, Maric K, Tendal B. Data extraction errors in meta-analyses that use standardized mean differences. JAMA 2007;298:430–437.
  • Goumakos W, Laussac JP, Sarkar B. Binding of cadmium(II) and zinc(II) to human and dog serum albumins. An equilibrium dialysis and 113Cd-NMR study. Biochem Cell Biol 1991;69:809–820.
  • Goyer RA. Mechanisms of lead and cadmium nephrotoxicity. Toxicol Lett 1989;46:153–162.
  • Granerus G, Aurell M. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest 1981;41:611–616.
  • Gräsbeck R. Imerslund-Gräsbeck syndrome (selective vitamin B(12) malabsorption with proteinuria). Orphanet J Rare Dis 2006;1:17.
  • Greenberg N, Roberts WL, Bachmann LM, Wright EC, Dalton RN, Zakowski JJ, Miller WG. Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles. Clin Chem 2012;58:391–401.
  • Guthrie CJG, Franklin DM, Scott MC, Chettle DR, Mason HJ, Smith NJ, et al. A longitudinal study of exposure to cadmium fume – preliminary findings from in vivo body burden measurements. In: Ellis KJ, Yasumura S, Morgan WD, editors. In vivo body composition studies. London: Institute of Physical Sciences in Medicine IPMS3; 1987. pp 348–356.
  • Harada A. Results of fifteen years health examinations on cadmium workers in a cadmium pigment factory (2nd report) (Japanese). Kankyo Hoken Rep 1987;53:219–233.
  • Harada T, Hara K, Ogata T, Nishimura K, Shigeno N, Shichijo T, Kuwazuka M, Sato S. Changes of main biochemical findings of subjects required observation in cadmium-polluted areas in Tsushima, Nagasaki Prefecture (in Japanese). Kankyo Hoken Rep 1991;58:205–211.
  • Harada T, Hirai Y, Hara K, Kamura S. A follow-up study on proximal renal tubular dysfunction in residents of a cadmium-polluted area requiring observation (in Japanese). Kankyo Hoken Rep 1988;54:127–133.
  • Harada A, Hirota M, Shibuya Y, Kohno K, Yoshida Y. Occupational health studies on cadmium workers. Kankyo Hoken Rep 1978;44:161–174.
  • Hatala R, Keitz S, Wyer PC, Guyatt G, for the Evidence-Based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. Can Med Assoc J 2005;172:661–665.
  • Hawkesworth S, Wagatsuma Y, Kippler M, Fulford AJ, Arifeen SE, Persson LA, Moore SE, Vahter M. Early exposure to toxic metals has a limited effect on blood pressure or kidney function in later childhood, rural Bangladesh. Int J Epidemiol 2013;42:176–185.
  • Hellström L, Elinder CG, Dahlberg B, Lundberg M, Järup L, Persson B, Axelson O. Cadmium exposure and end-stage renal disease. Am J Kidney Dis 2001;38:1001–1008.
  • Hellström L, Järup L, Persson B, Axelson O. Using environmental concentrations of cadmium and lead to assess human exposure and dose. J Expo Anal Environ Epidemiol 2004;14:416–423.
  • Herber RFM, Bernard A, Schaller K. Standardized method for the estimation of beta 2-microglobulin, retinol – binding protein and albumin in urine. Pure Appl Chem 1994;66:915–930.
  • Herber RFM, Stoeppler M, Tonks DB. Cooperative interlaboratory surveys of the determination of cadmium in whole blood. Fresenius J Anal Chem 1990;338:269–278.
  • Holden H. A mortality study of workers exposed to cadmium fumes. In: Edited Proceedings, editor. Cadmium 79. Edited proceedings of the second international cadmium conference, Cannes; 6–8 February 1979. London: Cadmium Association; 1980. pp 211–215.
  • Hortin GL, Meilinger B. Cross-reactivity of amino acids and other compounds in the biuret reaction: interference with urinary peptide measurements. Clin Chem 2005;51:1411–1419.
  • Hotz P, Buchet JP, Bernard A, Lison D, Lauwerys R. Renal effects of low level environmental cadmium exposure: five-year follow-up of a subcohort from the Cadmibel study. Lancet 1999;354:1508–1513.
  • Hsu CY, Chertow GM. Chronic renal confusion: insufficiency, failure, dysfunction, or disease. Am J Kidney Dis 2000;36:415–418.
  • Hsu CY, Chertow GM, Curhan GC. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 2002;61:1567–1576.
  • Hu H. Heavy metal poisoning. In: Longo DL, Kasper DL, Jameson JL, et al., editors. Harrison's principles of internal medicine. New York, Chicago, San Francisco: McGraw-Hill, Inc.; 2012. pp 1–4.
  • Hwangbo Y, Weaver VM, Tellezplaza M, Guallar E, Lee BK, Navasacien A. Blood cadmium and estimated glomerular filtration rate in Korean adults. Environ Health Perspect 2011;119:1800–1805.
  • Ikeda M, Ohashi F, Fukui Y, Sakuragi S, Moriguchi J. Cadmium, chromium, lead, manganese and nickel concentrations in blood of women in non-polluted areas in Japan, as determined by inductively coupled plasma-sector field-mass spectrometry. Int Arch Occup Environ Health 2011;84:139–150.
  • Inskip H, Beral V, McDowall M. Mortality of Shipham residents: 40-year follow-up. Lancet 1982;1:896–899.
  • IPCS. Cadmium environmental health criteria 134. Geneva: World Health Organization; 1992. pp 1–280.
  • Iwata K, Saito H, Nakano A. Association between cadmium-induced renal dysfunction and mortality: further evidence. Tohoku J Exp Med 1991;164:319–330.
  • Ix JH, de Boer IH, Wassel CL, Criqui MH, Shlipak MG, Whooley MA. Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the heart and soul study. Circulation 2010;121:1295–1303.
  • Jarrett JM, Xiao G, Caldwell KL, Henahan D, Shakirova G, Jones RL. Eliminating molybdenum oxide interference in urine cadmium biomonitoring using ICP-DRC-MS. J Anal At Spectrom 2008;23:962–967.
  • Järup L. Cadmium overload and toxicity. Nephrol Dial Transplant 2002;17:35–39.
  • Järup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 2009;238:201–208.
  • Järup L, Bellander T, Hogstedt C, Spang G. Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel. Occup Environ Med 1998a;55:755–759.
  • Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure – a review of the literature and a risk estimate. Scand J Work Environ Health 1998b;24:1–52.
  • Järup L, Persson B, Edling C, Elinder CG. Renal function impairment in workers previously exposed to cadmium. Nephron 1993;64:75–81.
  • Järup L, Persson B, Elinder CG. Decreased glomerular filtration rate in solderers exposed to cadmium. Occup Environ Med 1995;52:818–822.
  • Jin T, Nordberg M, Frech W, Dumont X, Bernard A, Ye TT, Kong Q, et al. Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China (ChinaCad). BioMetals 2002;15:397–410.
  • Jones-Burton C, Seliger SL, Scherer RW, Mishra SI, Vessal G, Brown J, Weir MR, Fink JC. Cigarette smoking and incident chronic kidney disease: a systematic review. Am J Nephrol 2007;27:342–351.
  • Juraschek SP, Coresh J, Inker LA, Levey AS, Kottgen A, Foster MC, Astor BC, et al. Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US Population. Clin J Am Soc Nephrol 2013;8:584–592.
  • Kah M, Levy L, Brown C. Potential for effects of land contamination on human health. 1. The case of cadmium. J Toxicol Environ Health Pt B 2012;15:348–363.
  • Kajikawa KI. Pathogenesis of Itai-itai disease based on post-mortem studies. In: Tsuchiya K, King Sted S, Hamagami CM, editors. Cadmium studies in Japan: a review. Amsterdam, New York, Oxford: Kodansha Ltd., Elsevier/North-Holland Biomedical Press, Elsevier North-Holland Inc.: 1978. pp 286–295.
  • Karmaus W, Dimitrov P, Simeonov V, Tsolova S, Bonev A, Georgieva R. Metals and kidney markers in adult offspring of endemic nephropathy patients and controls: a two-year follow-up study. Environ Health Global Access Sci Sour 2008;7:11.
  • Kasuya M, Teranishi H, Horiguchi H, Kato T, Aoshima K, Morikawa Y, et al. A fifteen-year study on renal dysfunction among people living in a cadmium polluted area. Kankyo Hoken Rep 1991;58:120–122.
  • Kazantzis G. Some long term effects of cadmium on the human kidney. In: Edited Proceedings, editor. Cadmium 77: edited proceedings of the first international cadmium conference San Francisco. London/New York: Metal Bulletin; Cadmium Association, London; Cadmium Council/International Lead Zinc Research Association, New York; 1978. pp 194–198.
  • Kazantzis G. Cadmium nephropathy. Contrib Nephrol 1979a;16:161–166.
  • Kazantzis G. Renal tubular dysfunction and abnormalities of calcium metabolism in cadmium workers. Environ Health Perspect 1979b;28:155–159.
  • Kazantzis G, Armstrong BG. Renal function in relation to low levels of cadmium exposure in a group of smelters workers. Environ Health Perspect 1984;54:193–199.
  • Kazantzis G, Blanks RG. A mortality study of cadmium exposed workers. In: Edited Proceedings, editor. Edited proceedings of the 7th international cadmium conference New Orleans. London: Cadmium Association; 1992. pp 150–157.
  • Kazantzis G, Blanks RG, Sullivan KR. Is cadmium a human carcinogen? IARC Sci Publ 1992;118:435–445.
  • Kazantzis G, Flynn FV, Spowage JS, Trott DG. Renal tubular malfunction and pulmonary emphysema in cadmium pigment workers. Q J Med 1963;32:165–192.
  • Kazantzis G, Lam TH, Sullivan KR. Mortality of cadmium-exposed workers. A five-year update. Scand J Work Environ Health 1988;14:220–223.
  • Kekwick RA. Physico-chemical examination of the serum and urine proteins in some cases of cadmium poisoning. Br J Ind Med 1955;12:196–197.
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013;1–150.
  • Kido T, Nogawa K, Ishizaki M, Honda R, Tsuritani I, Yamada Y, Nakagawa Y, Nakagawa H. Long-term observation of serum creatinine and arterial blood pH in persons with cadmium-induced renal dysfunction. Arch Environ Health 1990;45:35–41.
  • Kido T, Nordberg GF, Roels HA. Cadmium-induced renal effects. In: De Broe ME, Porter GA, Bennett WM, Verpooten GA, editors. Clinical nephrotoxins: renal injury from drugs and chemicals. Dordrecht: Kluwer Academic Publishers; 2003. pp 507–530.
  • Kim K. Blood cadmium concentration and lipid profile in Korean adults. Environ Res 2012;112:225–229.
  • King E. An environmental study of casting copper–cadmium alloys. Br J Ind Med 1955;12:198–205.
  • Kippler M, Ekstrom EC, Lonnerdal B, Goessler W, Akesson A, Elarifeen S, Persson LA, Vahter M. Influence of iron and zinc status on cadmium accumulation in Bangladeshi women. Toxicol Appl Pharmacol 2007;222:221–226.
  • Kippler M, Goessler W, Nermell B, Ekstrom EC, Lonnerdal B, Elarifeen S, Vahter M. Factors influencing intestinal cadmium uptake in pregnant Bangladeshi women – a prospective cohort study. Environ Res 2009;109:914–921.
  • Kippler M, Hoque AMW, Raqib R, Ohrvik H, Ekstrom EC, Vahter M. Accumulation of cadmium in human placenta interacts with the transport of micronutrients to the fetus. Toxicol Lett 2010a;192:162–168.
  • Kippler M, Nermell B, Hamadani J, Tofail F, Moore S, Vahter M. Burden of cadmium in early childhood: longitudinal assessment of urinary cadmium in rural Bangladesh. Toxicol Lett 2010b;198:20–25.
  • Kjellström T. Exposure and accumulation of cadmium in populations from Japan, the United States, and Sweden. Environ Health Perspect 1979;28:169–197.
  • Kjellström T. Renal effects. In: Friberg L, Elinder CG, Kjellström T, Nordberg GF, editors. Cadmium and health: a toxicological and epidemiological appraisal. Vol II: Effects and response. Boca Raton (FL): CRC Press, Inc.; 1986a. 21–110.
  • Kjellström T. Itai-itai disease. In: Friberg L, Elinder CG, Kjellström T, Nordberg GF, editors. Cadmium and health: a toxicological and epidemiological appraisal. Vol. II: Effects and response. Boca Raton (FL): CRC Press, Inc.; 1986b. pp 257–290.
  • Kjellström T, Evrin PE, Rahnster B. Dose–response analysis of cadmium-induced tubular proteinuria. A study of urinary ß2-microglobulin excretion among workers in a battery factory. Environ Res 1977;13:303–317.
  • Kjellström T, Friberg L, Rahnster B. Mortality and cancer morbidity among cadmium-exposed workers. Environ Health Perspect 1979;28:199–204.
  • Kliem V, Lonnemann G, Brunkhorst R. Durch Nephrotoxine verursachte tubulointerstitielle Nephropathien. Internist 1996;37:1116–1128.
  • Klooker P, Ritz E. Cadmium-induced renal damage: fact and fiction. Trace Elem Med 1986;3:67–71.
  • Kobayashi E, Suwazono Y, Honda R, Dochi M, Nishijo M, Kido T, Nakagawa H. Changes in renal tubular and glomerular functions and biological acid-base balance after soil replacement in Cd-polluted rice paddies calculated with a general linear mixed model. Biol Tr Elem Res 2008a;124:164–172.
  • Kobayashi E, Suwazono Y, Honda R, Dochi M, Nishijo M, Kido T, Nakagawa H. Serial changes in urinary cadmium concentrations and degree of renal tubular injury after soil replacement in cadmium-polluted rice paddies. Toxicol Lett 2008b;176:124–130.
  • Kobayashi E, Suwazono Y, Honda R, Dochi M, Nishijo M, Kido T, Nakagawa H. Serial follow-up study on renal handling of calcium and phosphorus after soil replacement in Cd-polluted rice paddies estimated using a general linear mixed model. Biol Tr Elem Res 2009;129:261–269.
  • Kowal NE, Johnson DE, Kraemer DF, Pahren HR. Normal levels of cadmium in diet, urine, blood, and tissues of inhabitants of the United States. J Toxicol Environ Health 1979;5:995–1014.
  • Kudo K, Konta T, Mashima Y, Ichikawa K, Takasaki S, Ikeda A, Hoshikawa M, et al. The association between renal tubular damage and rapid renal deterioration in the Japanese population: the Takahata study. Clin Exp Nephrol 2011;15:235–241.
  • Lalor GC. Review of cadmium transfers from soil to humans and its health effects and Jamaican environment. Sci Total Environ 2008;400:162–172.
  • Lambers Heerspink HJ, Gansevoort RT, Brenner BM, Cooper ME, Parving HH, Shahinfar S, De Zeeuw D. Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol 2010;21:1355–1360.
  • Lane RE, Campbell ACP. Fatal emphysema in to two men making a copper cadmium alloy. Br J Ind Med 1954;11:118–122.
  • Lauwerys R, Amery A, Bernard A, Bruaux P, Buchet JP, Claeys F, De Plaen P, et al. Health effects of environmental exposure to cadmium: objectives, design and organization of the Cadmibel study: a cross-sectional morbidity study carried out in Belgium from 1985 to 1989. Environ Health Perspect 1990;87:283–289.
  • Lauwerys R, Buchet JP, Roels H, Berlin A, Smeets J. Intercomparison program of lead, mercury, and cadmium analysis in blood, urine, and aqueous solutions. Clin Chem 1975;21:551–557.
  • Lauwerys R, De Wals P. Environmental pollution by cadmium and mortality from renal diseases (letter). Lancet 1981;i:383.
  • Lauwerys RR, Haufroid V, Hoet P, Lison D. Cadmium. In: Lauwerys RR, Haufroid V, Hoet P, Lison D, editors. Toxicologie industrielle et intoxications professionnelles. Paris: Masson; 2007. pp 203–239.
  • Lauwerys RR, Hoet P. Industrial chemical exposure. Guidelines for biological monitoring. Boca Raton (FL): Lewis Publishers; 2001. pp 1–638.
  • Lauwerys R, Vos A, Roels H, Buchet JP, Bernard A. Surveillance d'un travailleur ecarte de son poste de travail suite a la decouverte de lesions renales induites par le cadmium [Monitoring of a workman discharged from his place of business following discovery of renal lesions induced by cadmium]. Arch Belg Med Soc 1979;37:137–146.
  • Lepist EI, Zhang X, Hao J, Huang J, Kosaka A, Birkus G, Murray BP, et al. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat. Kidney Int 2014;86:350–357.
  • Lerner S, Hong CD, Bozian RC. Cadmium nephropathy – a clinical evaluation. J Occup Med 1979;21:409–412.
  • Levey AS, Coresh J. Chronic kidney disease. Lancet 2012;379:165–180.
  • Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F. Chronic Kidney Disease Epidemiology Collaboration. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007;53:766–772.
  • Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, Hendriksen S, Kusek JW, Vanlente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate [Correction in Ann Intern Med (2008) 149: 519]. Ann Intern Med 2006;145:247–254.
  • Li Q, Nishijo M, Nakagawa H, Morikawa Y, Sakurai M, Nakamura K, Kido T, et al. Relationship between urinary cadmium and mortality in habitants of a cadmium-polluted area: a 22-year follow-up study in Japan. Chin Med J 2011;124:3504–3509.
  • Liang YH, Lei LJ, Nilsson J, Li HQ, Nordberg M, Bernard A, Nordberg GF, et al. Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas. Environ Health Perspect 2012;120:223–228.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J 2009;339:b2700.
  • Lin CH, Chang LW, Chang H, Yang MH, Yang CS, Lai WH, Chang WH, Lin P. et al. The chemical fate of the Cd/Se/Te-based quantum dot 705 in the bioligical system: toxicity implications. Nanotechnology 2009a;20:215101–215109.
  • Lin P, Chen JW, Chang LW, Wu JP, Redding L, Chang H, Yeh TK, et al. Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice. Environ Sci Technol 2008;42:6264–6270.
  • Lin YS, Rathod D, Ho WC, Caffrey JJ. Cadmium exposure is associated with elevated blood C-reactive protein and fibrinogen in the U.S. population: The Third National Health and Nutrition Examination Survey (NHANES III, 1988–1994). Ann Epidemiol 2009b;19:592–596.
  • Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278–285.
  • Lindqvist B, Nyström K, Stegmayr B, Wirell M, Eriksson A. Cadmium concentration in human kidney biopsies. Scand J Urol Nephrol 1989;23:213–217.
  • Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, Vikse BE. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 2013;382:273–283.
  • Martin CJ, Antonini JM, Doney BC. A case report of elevated blood cadmium. Occup Med 2009;59:130–132.
  • Maruzeni S, Nishijo M, Nakamura K, Morikawa Y, Sakurai M, Nakashima M, Kido T, et al. Mortality and causes of deaths of inhabitants with renal dysfunction induced by cadmium exposure of the polluted Jinzu River basin, Toyama, Japan; a 26-year follow-up. Environ Health Global Access Sci Sour 2014;13:18.
  • Mason HJ, Stevenson AJ, Williams N, Morgan M. Intra-individual variability in markers of proteinuria for normal subjects and those with cadmium-induced renal dysfunction: interpretation of results from untimed, random urine samples. Biomarkers 1999b;4:118–128.
  • Mason HJ, Williams N, Armitage S, Morgan M, Green S, Perrin B, Morgan WD. Follow up of workers previously exposed to silver solder containing cadmium. Occup Environ Med 1999a;56:553–558.
  • Matsushita K, Ballew SH, Astor BC, de Jong PE, Gansevoort RT, Hemmelgarn BR, Levey AS, et al. Cohort profile: The Chronic Kidney Disease Prognosis Consortium. Int J Epidemiol 2013;42:1660–1668.
  • Matsushita K, Vandervelde M, Astor BC, Woodward M, Levey AS, Dejong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073–2081.
  • Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230–235.
  • McKenzie JM, Kay DL. Urinary excretion of cadmium, zinc and copper in normotensive and hypertensive women. NZ Med J 1973;78:68–70.
  • Meerkin M, Clarke R, Oliphant R. Chronic cadmium poisoning. Med J Aust 1976;1:23–24.
  • Menke A, Muntner P, Silbergeld EK, Platz EA, Guallar E. Cadmium levels in urine and mortality among US adults. Environ Health Perspect 2009;117:190–196.
  • Mertz DP, Koschnick R, Wilk G. Renale Ausscheidungsbedingungen von Cadmium beim normotensiven und hypertensiven Menschen [The renal excretion of cadmium in normotensive and hypertensive humans‘(German). Z Klin Chem u Klin Biochem 1972;10:21–24.
  • Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, Mcqueen MJ, Itoh Y, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009;55:24–38.
  • Miyamoto Y. Clinical record and autopsy report of an 83-year-old male inhabitant of Hyogo prefecture. In: Tsuchiya K, King Sted S, Hamagami CM, editors. Cadmium studies in Japan: a review. Amsterdam, New York, Oxford: Kodansha Ltd., Elsevier/North-Holland Biomedical Press, Elsevier North-Holland Inc.; 1978. pp 319–325.
  • Miyata T, Jadoul M, Kurokawa K, Destrihou CV. Beta-2 microglobulin in renal disease. J Am Soc Nephrol 1998;9:1723–1735.
  • Morgan H. Intakes of metal. Sci Total Environ 1988;75:71–100.
  • Moriguchi J, Ezaki T, Tsukahara T, Fukui Y, Ukai H, Okamoto S, Shimbo S, et al. Effects of aging on cadmium and tubular dysfunction markers in urine from adult women in non-polluted areas. Int Arch Occup Environ Health 2005;78:446–451.
  • Moynihan R, Glassock R, Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased. Br Med J 2013;347:f4298.
  • Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, et al. Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the National Kidney Disease Education Program. Clin Chem 2006;52:5–18.
  • Myong JP, Kim HR, Baker D, Choi B. Blood cadmium and moderate-to-severe glomerular dysfunction in Korean adults: analysis of KNHANES 2005–2008 data. Int Arch Occup Environ Health 2012;85:885–893.
  • Nagasawa Y, Yamamoto R, Rakugi H, Isaka Y. Cigarette smoking and chronic kidney diseases. Hypertens Res 2012;35:261–265.
  • Nakagawa H, Kawano S, Okumura Y, Fujita T, Nishi M. Mortality study of inhabitants in a cadmium-polluted area. Bull Environ Contam Toxicol 1987;38:553–560.
  • Nakagawa H, Nishijo M, Morikawa Y, Miura K, Tawara K, Kuriwaki J, Kido T, et al. Urinary cadmium and mortality among inhabitants of a cadmium-polluted area in Japan. Environ Res 2006;100:323–329.
  • Nakagawa H, Nishijo M, Morikawa Y, Tabata M, Miura K, Takahara H, Okumura Y, et al. Increased urinary beta2-microglobulin and mortality rate by cause of death in a cadmium-polluted area. Environ Health Prev Med 1996;1:144–148.
  • Nakagawa H, Nishijo M, Morikawa Y, Tabata M, Senma M, Kitagawa Y, Kawano S, et al. Urinary beta 2-microglobulin concentration and mortality in a cadmium-polluted area. Arch Environ Health 1993;48:428–435.
  • Nanayakkara S, Komiya T, Ratnatunga N, Senevirathna STMLD, Harada KH, Hitomi T, Gobe G, et al. Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka. Environ Health Prev Med 2012a;17:213–221.
  • Nanayakkara S, Senevirathna STMLD, Karunaratne U, Chandrajith R, Harada KH, Hitomi T, Watanabe T, et al. Evidence of tubular damage in the very early stage of chronic kidney diseae of uncertain etiology in the North Central Province of Sri Lanka: a cross-sectional study. Environ Health Prev Med 2012b;17:109–117.
  • National Kidney Disease Education Programme. Estimating GFR. 2014. Available from: http://nkdep nih gov/lab-evaluation/gfr/estimating shtml. Accessed on 17 Jan 2015.
  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39:1–237.
  • Navasacien A, Tellezplaza M, Guallar E, Muntner P, Silbergeld E, Jaar B, Weaver V. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 2009;170:1156–1164.
  • Nawrot TS, Vanhecke E, Thijs L, Richart T, Kuznetsova T, Jin Y, Vangronsveld J, et al. Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population. Environ Health Perspect 2008;116:1620–1628.
  • Nicholson G, Fynn J, Coroneos N. Cadmium poisoning in a crematorium worker. Anaesth Intensive Care 1997;25:163–165.
  • Nicholson JK, Higham DP, Timbrell JA, Sadler PJ. Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. Mol Pharmacol 1989;36:398–404.
  • Nielsen R, Christensen EI. Proteinuria and events beyond the slit. Pediatr Nephrol 2010;25:813–822.
  • Nishijo M, Morikawa Y, Nakagawa H, Tawara K, Miura K, Kido T, Ikawa A, et al. Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment. Occup Environ Med 2006;63:545–550.
  • Nishijo M, Nakagawa H, Morikawa Y, Kuriwaki JI, Miura K, Kido T, Nogawa K. Mortality in a cadmium polluted area in Japan. BioMetals 2004;17:535–538.
  • Nishijo M, Nakagawa H, Morikawa M, Tabata M, Miura T, Yoshita K, Higashiguchi K, et al. Relationship between urinary cadmium and mortality among inhabitants living in a cadmium polluted area in Japan. Toxicol Lett 1999;108:321–327.
  • Nishijo M, Nakagawa H, Morikawa Y, Tabata M, Senma M, Kitagawa Y, Kawano S, et al. Prognostic factors of renal dysfunction induced by environmental cadmium pollution. Environ Res 1994;64:112–121.
  • Nishijo M, Nakagawa H, Morikawa Y, Tabata M, Senma M, Miura K, Takahara H, et al. Mortality of inhabitants in an area polluted by cadmium: 15 year follow up. Occup Environ Med 1995;52:181–184.
  • Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. Br Med J 2013;346:f324.
  • Nogawa K. Itai-itai disease and follow-up studies. In: Nriagu JO, editor. Cadmium in the environment. Part 2. Health effects. New York, Chichester, Brisbane: John Wiley & Sons; 1981. pp 3–37.
  • Nogawa K, Ishizaki A, Fukushima M, Shibata I, Hagino M. Studies on the women with acquired Fanconi syndrome observed in the Ichi River basin polluted by cadmium. Is this Itai-itai disease? Environ Res 1975;10:280–307.
  • Nogawa K, Kido T. Biological monitoring of cadmium exposure in itai-itai disease epidemiology. Int Arch Occup Environ Health 1993;65:S43–S46.
  • Nogawa K, Kobayashi E, Honda R, Ishizaki A. A follow up study on urinary findings of patients with and suspected of Itai-Itai disease (in Japanese). Jpn J Public Health 1979;26:25–31.
  • Nogawa K, Kobayashi E, Okubo Y, Suwazono Y. Environmental cadmium exposure, adverse effects, and preventive measures in Japan. BioMetals 2004;17:581–587.
  • Nomiyama K. Renal effects of cadmium. In: Nriagu JO, editor. Cadmium in the environment. Part 2. Health effects. New York, Chichester, Brisbane: John Wiley & Sons; 1981. pp 644–689.
  • Nordberg G. Cadmium and human health: a perspective based on recent studies in China. J Trace Elem Exp Med 2003;16:307–319.
  • Nordberg GF. Historical perspectives on cadmium toxicology. Toxicol Appl Pharmacol 2009;238:192–200.
  • Nordberg GF, Jin T, Kong Q, Ye T, Cai S, Wang Z, Zhuang F, Wu X. Biological monitoring of cadmium exposure and renal effects in a population group residing in a polluted area in China. Sci Total Environ 1997;199:111–114.
  • Nordberg G, Jin TY, Wu XW, Lu J, Chen L, Liang YH, Lei LJ, et al. Kidney dysfunction and cadmium exposure – factors influencing dose–response relationships. J Trace Elem Med Biol 2012;26:197–200.
  • Nordberg GF, Nogawa K, Nordberg M, Friberg LT. Cadmium. In: Nordberg GF, Fowler BA, Nordberg M, Friberg LT, editors. Handbook of the toxicology of metals. Amsterdam, Boston, Heidelberg: Elsevier; 2007. pp 445–486. Note: a 4th edition of the Handbook on the Toxicology of Metals (2014) is now available.
  • Nordberg GF, Piscator M, Nordberg M. On the distribution of cadmium in blood. Acta Pharmacol Toxicol 1971;30:289–295.
  • Occupational Medicine Forum. Have there been any significant developments in the knowledge of cadmium since the OSHA standard of 1991? J Occup Environ Med 2006;48:102–104.
  • Omarova A, Phillips CJC. A meta-analysis of literature data relating to the relationships between cadmium intake and toxicity indicators in humans. Environ Res 2007;103:432–440.
  • Onodera M, Sakurai H, Hosoda K, Omae K. Early health effects in cadmium exposed female workers (Japanese). Sangyo Igaku 1988;30:402–403.
  • Onodera A, Tani M, Michigami T, Yamagata M, Min KS, Tanaka K, Nakanishi T, et al. Role of megalin and the soluble form of its ligand RAP in Cd-metallothionein endocytosis and Cd-metallothionein-induced nephrotoxicity in vivo. Toxicol Lett 2012;212:91–96.
  • Oterdoom LH, Gansevoort RT, Schouten JP, De Jong PE, Gans RO, Bakker SJ. Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis 2009;207:534–540.
  • Philipp R. Cadmium-risk assessment of an exposed residential population: a review. J R Soc Med 1985;78:328–333.
  • Piscator M. Proteinuria in chronic cadmium poisoning. 1. An electrophoretic and chemical study of urinary and serum proteins from workers with chronic cadmium poisoning. Arch Environ Health 1962a;4:607–621.
  • Piscator M. Proteinuria in chronic cadmium poisoning. 2. The applicability of quantitative and qualitative methods of protein determination for the demonstration of cadmium proteinuria. Arch Environ Health 1962b;5:325–332.
  • Piscator M. Proteinuria in chronic cadmium poisoning. III. Electrophoretic and immunoelectrophoretic studies on urinary proteins from cadmium workers, with special reference to the excretion of low molecular weight proteins. Arch Environ Health 1966;12:335–344.
  • Piscator M. Proteinuria as an index of renal injury with special reference to chronic cadmium poisoning. In: Holden H, Kazantzis G, editors. Proceedings of the symposium on the early detection of occupational hazards (April 1970). London: Society of Occupational Medicine; 1971. pp 21–34.
  • Piscator M. The progress of renal dysfunction in cadmium-exposed persons. In: Wilson D, Volpe RA, editors. Cadmium 83. Edited proceedings. Fourth international cadmium conference. Munich. London, New York: Cadmium Association, Cadmium Council Inc., International Lead Zinc Research Association; 1983a. pp 157–160.
  • Piscator M. The importance of quality control for estimating dose–effect and dose–response relationships. In: Bratter P, Schramel P, editors. Proceedings of the second international workshop, Neuherberg, Federal Republic of Germany, April 1982. Vol. 2: Trace element analytical chemistry in medicine and biology. Berlin, New York: Walter de Gruyter; 1983b. pp 747–764.
  • Piscator M. Long-term observations on tubular and glomerular function in cadmium-exposed persons. Environ Health Perspect 1984;54:175–179.
  • Piscator M, Pettersson B. Chronic cadmium poisoning – diagnosis and prevention. In: Brown SS, editor. Clinical chemistry and chemical toxicology of metals. Proceedings of the first international symposium organized by the commission on toxicology. Amsterdam, New York: Elsevier/North Holland; 1977. pp 143–155.
  • Poggio ED, Wang X, Greene T, Vanlente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft–Gault equations health and in chronic kidney in the estimation of GFR in disease. J Am Soc Nephrol 2005;16:459–466.
  • Pottel H, Hoste L, Delanaye P, Cavalier E, Martens F. Demystifying ethnic/sex differences in kidney function: is the difference in (estimating) glomerular filtration rate or in serum creatinine concentration? Clin Chim Acta 2012;413:1612–1617.
  • Potts CL. Cadmium proteinuria – the health of battery workers exposed to cadmium oxide dust. Ann Occup Hyg 1965;8:55–61.
  • Priem F, Althaus H, Birnbaum M, Sinha P, Conradt HS, Jung K. Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem 1999;45:567–568.
  • Pruss-Ustun A, Vickers C, Haefliger PBR. Knowns and unknowns on burden of disease due to chemicals: a systematic review. Environ Health Global Access Sci Sour 2011;10:9.
  • Ramirez-Rubio O, Mcclean MD, Amador JJ, Brooks DR. An epidemic of chronic kidney disease in Central America: an overview. J Epidemiol Community Health 2013;67:1–3.
  • Rentschler G, Kippler M, Axmon A, Raqib R, Ekstrom EC, Skerfving S, Vahter M, Broberg K. Polymorphisms in iron homeostasis genes and urinary cadmium concentrations among nonsmoking women in Argentina and Bangladesh. Environ Health Perspect 2013;121:467–472.
  • Richter PA, Bishop EE, Wang J, Swahn MH. Tobacco smoke exposure and levels of urinary metals in the U.S. youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Int J Environ Res Public Health 2009;6:1930–1946.
  • Roels H, Djubgang J, Buchet JP, Bernard A, Lauwerys R. Evolution of cadmium-induced renal dysfunction in workers removed from exposure. Scand J Work Environ Health 1982;8:191–200.
  • Roels HA, Lauwerys RR, Buchet JP, Bernard AM, Vos A, Oversteyns M. Health significance of cadmium induced renal dysfunction: a five year follow up. Br J Ind Med 1989;46:755–764.
  • Roels HA, Van Assche FJ, Oversteyns M, De Groof M, Lauwerys RR, Lison D. Reversibility of microproteinuria in cadmium workers with incipient tubular dysfunction after reduction of exposure. Am J Ind Med 1997;31:645–652.
  • Rothman KJ, Greenland S, Lash TL. Validity in epidemiologic studies. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. Philadelphia, Baltimore, New York: Wolters Kluwer Lippincott Williams & Wilkins; 2008. pp 128–147.
  • Ruilope LM. Renal damage in hypertension. J Cardiovasc Risk 1995;2:40–44.
  • Rule AD, Bailey KR, Turner ST. What is the goal with endogenous filtration markers – estimation of GFR or prediction of kidney outcomes? Am J Kidney Dis 2011;58:865–867.
  • Sakurai H. Epidemiological studies. In: Tsuchiya K, King Sted S, Hamagami CM, editors. Cadmium studies in Japan: a review. Amsterdam, New York, Oxford: Kodansha Ltd., Elsevier/North-Holland Biomedical Press, Elsevier North-Holland Inc.; 1978. pp 133–268.
  • Sandberg T, Cooper EH, Lidin-Janson G, Yu H. Fever and proximal tubular function in acute pyelonephritis. Nephron 1985;41:39–44.
  • Santoyo-Sanchez MP, Pedraza-Chaverri J, Molina-Jijon E, Arreola-Mendoza L, Rodriguez-Munoz R, Barbier OC. Impaired endocytosis in proximal tubule from subchronic exposure to cadmium involves angiotensin II type 1 and cubilin receptors. BMC Nephrol 2013;14:211.
  • Sartor FA, Rondia DJ, Claeys FD, Staessen JA, Lauwerys RR, Bernard AM, Buchet JP, et al. Impact of environmental cadmium pollution on cadmium exposure and body burden. Arch Environ Health 1992;47:347–353.
  • Satarug S, Garrett SH, Sens MA, Sens DA. Cadmium, environmental exposure, and health outcomes. Environ Health Perspect 2010;118:182–190.
  • Savolainen H. Cadmium-associated renal disease. Ren Fail 1995;17:483–487.
  • Scott R, Aughey E, Fell GS, Quinn MJ. Cadmium concentrations in human kidneys from the UK. Hum Toxicol 1987;6:111–119.
  • Scott R, Caine N, Hall D, McKellar N, Fell GS. A prospective study of coppersmiths following cadmium exposure. Nutr Res 1985;5:S618–S621.
  • Scott R, Cunningham C, McLelland A, Fell GS, Fitzgerald-Finch OP, McKellar N. The importance of cadmium as a factor in calcified upper urinary tract stone disease – a prospective 7-year study. Br J Urol 1982;54:584–589.
  • Scott R, Paterson PJ, Mills EA, McKirdy A, Fell GS, Ottoway JM, Husain FER, et al. Clinical and biochemical abnormalities in coppersmiths exposed to cadmium. Lancet 1976;2:396–398.
  • Shiba KS, Kanamori K, Harada T, Nakao M, Nakajima K, Kodaira T, Nakagawa H. A cause of discrepancy between values for urinary protein as assayed by the coomassie brilliant blue G-250 method and sulfosalicylic acid method. Clin Chem 1985;31:1215–1218.
  • Shibuya Y. A long-term surveillance of occupational health hazards faced by cadmium workers. Kitasato Arch Exp Med 1990;63:37–48.
  • Shigematsu I, Kawaguchi T, Yanagawa H. Reanalysis of the results of health examinations conducted on the general population in the cadmium-polluted areas of Japan (with appendix C; pp. 327–367). In: Tsuchiya K, King Sted S, Hamagami CM, editors. Cadmium studies in Japan: a review. Amsterdam, New York, Oxford: Kodansha Ltd., Elsevier/North-Holland Biomedical Press, Elsevier North-Holland Inc.; 1978. pp 253–267.
  • Shiroishi K, Kjellström T, Kubota K, Evrin PE, Anayama M, Vesterberg O, Shimada T, et al. Urine analysis for detection of cadmium-induced renal changes, with special reference to β2-microglobulin. A cooperative study between Japan and Sweden. Environ Res 1977;13:407–424.
  • Smith JC, Kench JE. Observations on urinary cadmium and protein excretion in men exposed to cadmium oxide dust and fume. Br J Ind Med 1957;14:240–245.
  • Smith JC, Kench JE, Lane RE. Determination of cadmium in urine and observations on urinary cadmium and protein excretion in men exposed to cadmium oxide dust. Biochem J 1955;61:698–701.
  • Smith JC, Kench JE, Smith JP. Chemical and histological post-mortem studies on a workman exposed for many years to cadmium oxide fume. Br J Ind Med 1957;14:246–249.
  • Smith JP, Smith JC, McCall AJ. Chronic poisoning from cadmium fume. J Path Bact 1960;80:287–296.
  • Sommar JN, Svensson MK, Bjor BM, Elmstahl SI, Hallmans G, Lundh T, Schon SM, et al. End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ Health 2013;12:9.
  • Sorahan T. A mortality study of nickel-cadmium battery workers. In: Edited Proceedings, editor. Edited proceedings from the 3rd international cadmium conference, February 1981. London: Cadmium Association; 1982. pp 138–141.
  • Sorahan T, Adams RG, Waterhouse JAH. Analysis of mortality from nephritis and nephrosis among nickel–cadmium battery workers. J Occup Med 1983;25:609–612.
  • Sorahan T, Waterhouse JAH. Mortality study of nickel-cadmium battery workers by the method of regression models in life tables. Br J Ind Med 1983;40:293–300.
  • Staessen J, Amery A, Bernard A, Bruaux P, Buchet JP, Bulpitt CJ, Claeys F, et al. Blood pressure, the prevalence of cardiovascular diseases, and exposure to cadmium: a population study. Am J Epidemiol 1991;134:257–267.
  • Staessen JA, Buchet JP, Lauwerys RR, Roels H, Thijs L, Fagard R. Environmental cadmium pollution and public health: the Belgian experience. Arch Public Health 1995;53:9–34.
  • Staessen JA, Lauwerys RR, Ide G, Roels HA, Vyncke G, Amery A. Renal function and historical environmental cadmium pollution from zinc smelters. Lancet 1994;343:1523–1527.
  • Starkey BJ, Taylor A, Walker AW. Blood cadmium determination – results of an external quality assessment scheme. J Anal At Spectrom 1986;1:397–400.
  • Stephens GA. Cadmium poisoning. J Indust Hyg 1920;2:129–132.
  • Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, Nelson RG, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 2011;79:555–562.
  • Stewart M, Hughes EG. Urinary beta 2 microglobulin in the biological monitoring of cadmium workers. Br J Ind Med 1981;38:170–174.
  • Storm T, Emma F, Verroust PJ, Hertz JM, Nielsen R, Christensen EI. A patient with cubilin deficiency. N Engl J Med 2011;364:89–91.
  • Strehlow CD, Barltrop D. Health studies. Sci Total Environ 1988;75:101-133.
  • Streiner DL, Norman GR. Correction for multiple testing. Is there a resolution? Chest 2011;140:16–18.
  • Sumino K, Hayakawa K, Shibata T, Kitamura S. Heavy metals in normal Japanese tissues. Amounts of 15 heavy metals in 30 subjects. Arch Environ Health 1975;30:487–490.
  • Suzuki S, Suzuki T, Ashizawa M. Proteinuria due to inhalation of cadmium stearate dust. Ind Health 1965;3:73–85.
  • Swaddiwudhipong W, Limpatanachote P, Mahasakpan P, Krintratun S, Padungtod C. Cadmium-exposed population in Mae Sot District, Tak Province: 1. Prevalence of high urinary cadmium levels in the adults. J Med Assoc Thai 2007;90:143–148.
  • Swaddiwudhipong W, Limpatanachote P, Mahasakpan P, Krintratun S, Punta B, Funkhiew T. Progress in cadmium-related health effects in persons with high environmental exposure in northwestern Thailand: a five-year follow-up. Environ Res 2012a;112:194–198.
  • Swaddiwudhipong W, Limpatanachote P, Mahasakpan P, Krintratun S, Punta B, Funkhiew T. Response to a commentary by Wiwanitkit (2011) on a report by Swaddiwudhipong et al. (2011) (letter). Environ Res 2012b;112:237–238.
  • Swaddiwudhipong W, Limpatanachote P, Nishijo M, Honda R, Mahasakpan P, Krintratun S. (2010). Cadmium-exposed population in Mae Sot district, Tak province: 3. Associations between urinary cadmium and renal dysfunction, hypertension, diabetes, and urinary stones. J Med Assoc Thai, 93, 231-8.
  • Swaen GGMH, Teggeler O, Vanamelsvoort LGPM. False positive outcomes and design characteristics in occupational cancer epidemiology studies. Int J Epidemiol 2001;30:948–954.
  • Takebayashi S, Harada T, Kamura S. Clinical and pathological findings of the eleventh autopsy case in the cadmium polluted area in Tsushima Island, Nagasaki Prefecture (in Japanese). Kankyo Hoken Rep 1988;54:207–213.
  • Takebayashi S, Harada T, Kamura S, Satoh T, Segawa M, Yajima K. Cadmium-induced osteopathy: clinical and autopsy findings of four patients. Appl Pathol 1987;5:190–197.
  • Takebayashi S, Jimi S, Segawa M, Kiyoshi Y. Cadmium induces osteomalacia mediated by proximal tubular atrophy and disturbances of phosphate reabsorption. A study of 11 autopsies. Pathol Res Pract 2000;196:653–663.
  • Toda A. Physical examination and autopsy report of a 74-year-old female inhabitant of Hyogo prefecture. In: Tsuchiya K, King Sted S, Hamagami CM, editors. Cadmium studies in Japan: a review. Amsterdam, New York, Oxford: Kodansha Ltd.; Elsevier/North-Holland Biomedical Press; Elsevier North-Holland Inc.; 1978. pp 307–318.
  • Tonna SJ. Defining incident chronic kidney disease in epidemiologic study setting. Am J Epidemiol 2009;170:425–427.
  • Trevisan A, Gardin C. Nephrolithiasis in a worker with cadmium exposure in the past. Int Arch Occup Environ Health 2005;78:670–672.
  • Trevisan A, Maso S. Indicatori biologici di effetto renale in lavoratori con pregressa asposizione a cadmio: follow-up di cinque anni. Med Lav 1991;82:542–546.
  • Tsuchiya K. Proteinuria of workers exposed to cadmium fume. The relationship to concentration in the working environment. Arch Environ Health 1967;14:875–880.
  • Tsuchiya K. Proteinuria of cadmium workers. J Occup Med 1976;18:463–466.
  • Tsuchiya K. Conclusion. In: Tsuchiya K, King Sted S, Hamagami CM, editors. Cadmium studies in Japan: a review. Amsterdam, New York, Oxford: Kodansha Ltd., Elsevier/North-Holland Biomedical Press, Elsevier North-Holland Inc.; 1978. pp 301–305.
  • Tsuchiya K. Clinical signs, symptoms, and prognosis of cadmium poisoning. In: Nriagu JO, editor. Cadmium in the environment. Part 2. Health effects. New York, Chichester, Brisbane: John Wiley & Sons; 1981. pp 40–54.
  • Tsuchiya K. Health effects of cadmium with special reference to studies in Japan. IARC Sci Publ 1992;118:35–49.
  • Tyner M. Investigation of elevated urine beta-2-microglobulin in a cohort of cadmium workers. J Occup Environ Med 1999;41:745–746.
  • Vahter M, Berglund M, Akesson A, Liden C. Metals and women's health. Environ Res 2002;88:145–155.
  • Vahter M, Friberg L. Quality control in integrated human exposure monitoring of lead and cadmium. Fresenius Z Anal Chem 1988;332:726–731.
  • Vahter ME, Li L, Nermell B, Rahman A, El AS, Rahman M, Persson LA, Ekstrom EC. Arsenic exposure in pregnancy: a population-based study in Matlab, Bangladesh. J Health Popul Nutr 2006;24:236–245.
  • Vale JA. Cadmium-induced nephrotoxicity: a biochemical or clinical disease (abstract). Clin Toxicol 2009;47:490–491.
  • Vallon V, Eraly SA, Rao SR, Gerasimova M, Rose M, Nagle M, Anzai N, et al. A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am J Physiol Renal Physiol 2012;302:F1293–F1299.
  • Van Lente F, Suit P. Assessment of renal function by serum creatinine and creatinine clearance: glomerular filtration rate estimated by four procedures. Clin Chem 1989;35:2326–2329.
  • van Sittert NJ, Ribbens PH, Huisman B, Lugtenburg D. A nine year follow up study of renal effects in workers exposed to cadmium in a zinc ore refinery. Br J Ind Med 1993;50:603–612.
  • Verougstraete V. Evaluation of the health effects of cadmium: application of systematic review. Bruxelles: Thèse, Université Catholique de Louvain; 2005. pp 1–263.
  • Vuori E, Huunan-Seppala A, Kilpio JO, Salmela SS. Biologically active metals in human tissues. II. The effect of age on the concentration of cadmium in aorta, heart, kidney, liver, lung, pancreas and skeletal muscle. Scand J Work Environ Health 1979;5:16–22.
  • Wallin M, Sallsten G, Lundh T, Barregard L. Low-level cadmium exposure and effects on kidney function. Occup Environ Med 2014;71:848–854.
  • Weaver VM, Kim NS, Lee BK, Parsons PJ, Spector J, Fadrowski J, Jaar BG, et al. Differences in urine cadmium associations with kidney outcomes based on serum creatinine and cystatin C. Environ Res 2011;111:1236–1242.
  • Weaver VM, Kotchmar DJ, Fadrowski JJ, Silbergeld EK. Challenges for environmental epidemiology research: are biomarker concentrations altered by kidney function or urine concentration adjustment? J Expo Sci Environ Epidemiol 2015;1–8.
  • Weber MH, Verwiebe R. α1-microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction. Eur J Clin Chem Clin Biochem 1992;30:683–691.
  • Wedeen RP. Occupational renal disease. Am J Kidney Dis 1984;3:241–257.
  • Wedeen RP. Environmental renal disease: lead, cadmium and Balkan endemic nephropathy. Kidney Int 1991;40:S4–S8.
  • Wedeen RP. Occupational and environmental renal disease. Semin Nephrol 1997;17:46–53.
  • Wennberg M, Lundh T, Bergdahl IA, Hallmans G, Jansson JH, Stegmayr B, Custodio HM, Skerfving S. Time trends in burdens of cadmium, lead, and mercury in the population of northern Sweden. Environ Res 2006;100:330–338.
  • Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH. The epidemic of chronic kidney disease of unknown etiology in Mesoamerica: a call for interdisciplinary research and action. Am J Public Health 2013;103:1927–1930.
  • Wester PO. Trace elements in serum and urine from hypertensive patients before and during treatment with chlorthalidone. Acta Med Scand 1973;194:505–512.
  • White CA, Ghazan-Shahi S, Adams MA. β-Trace protein: a marker of GFR and other biological pathways. Am J Kidney Dis 2015;65:131–146.
  • Wilhelm M, Ewers U, Schulz C. Revised and new reference values for some trace elements in blood and urine for human biomonitoring in environmental medicine. Int J Hyg Environ Health 2004;207:69–73.
  • Winearls CG, Glassock RJ. Classification of chronic kidney disease in the elderly: pitfalls and errors. Nephron Clin Pract 2011;119:c2–c4.
  • Wolff NA, Abouhamed M, Verroust PJ, Thevenod F. Megalin-dependent internalization of cadmium-metallothionein and cytotoxicity in cultured renal proximal tubule cells. J Pharmacol Exp Ther 2006;318:782–791.
  • Wright PRD, Rattray R, Lalor G, Hanson R. Minimal health impact from exposure to diet-sourced cadmium on a population in central Jamaica. Environ Geochem Health 2010;32:567–581.
  • Wu CK, Chang MH, Lin JW, Caffrey JL, Lin YS. Renal-related biomakers and long-term mortality in the US subjects with different coronary risks. Atherosclerosis 2011;216:226–236.
  • Wu XW, Liang YH, Jin TY, Ye TT, Kong QH, Wang ZJ, Lei LJ, et al. Renal effects evolution in a Chinese population after reduction of cadmium exposure in rice. Environ Res 2008;108:233–238.
  • Yamagata N. Analytical methods. In: Tsuchiya K, King Sted S, Hamagami CM, editors. Cadmium studies in Japan: a review. Amsterdam, New York, Oxford: Kodansha Ltd., Elsevier/North-Holland Biomedical Press, Elsevier North-Holland Inc.; 1978. pp 11–18.
  • Yaqub F. Kidney disease in farming communities remains a mystery. Lancet 2014;383:1794–1795.
  • Yasuda M, Miwa A, Kitagawa M. Morphometric studies of renal lesions in Itai-itai disease: chronic cadmium nephropathy. Nephron 1995;69:14–19.
  • Ye L, Yong KT, Liu L, Roy I, Hu R, Zhu J, Cai H, et al. A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots. Nat nanotechnol 2012;7:453–458.
  • Yeh TK, Wu JP, Chang LW, Tsai MH, Chang WH, Tsai HT, Yang CS, Lin PP. Comparative tissue distributions of cadmium chloride and cadmium-based quantum dot 705 in mice: safety implications and applications. Nanotoxicology 2011;5:91–97.
  • Yong KT, Swihart MT. In vivo toxicity of quantum dots: no cause for concern? Nanomedicine 2012;7:1641–1643.
  • Zhou XJ, Rakheja D, Yu XQ, Saxena R, Vaziri ND, Silva FG. The aging kidney. Kidney Int 2008;74:710–720.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.